Shares of Portola Pharmaceuticals (NASDAQ:PTLA) -- a biopharmaceutical company that focuses on the development of treatments for life-threatening blood disorders -- are up by a whopping 129% as of 12:11 p.m. EDT on Tuesday.Alexion believes Andexxa still has significant untapped potential, and the biotech company will look to expand the number of patients who benefit from this drug "while also driving value for shareholders."